
Uruguayan company offers complete solutions for high-quality CBD products

Company seeks to transform the perception of hemp and streamline processes in the healthcare field

Participation in the Medical Cannabis Fair 2024 marks a new chapter in the company's history

This measure, published through Resolution SS 107 of 07/05/24, aims to guide physicians in the prescription and criteria for the use of these medications for patients with specific syndromes

Committed to social transformation, Instituto Santa Planta seeks to change the mindset regarding the cultivation and therapeutic use of cannabis

Court orders health plan to cover treatment with cannabidiol (CBD)

Drug Enforcement Administration (DEA) will adjust the classification, moving the plant from Schedule I to Schedule III. 'Historical reparation,' says expert

Demystifying concerns and highlighting findings

How cannabis is reaching the profitability of companies like Amazon and Coca-Cola

With an initial investment of approximately R$106 million, the company offers sustainable innovation, quality, and pharmaceutical standards of excellence

Minas is one of the few states that still do not have approved legislation on the free distribution of cannabidiol-based medicines

3rd Brazilian Congress on Medicinal Cannabis brings together leading figures in the sector to promote health, well-being, and quality of life

On April 1, the law that partially legalizes the use of marijuana in the country came into effect with restrictions on public places, such as schools, daycare centers, and sports areas.

Facilitating the path to business success is one of the company's objectives, which this year will participate in MCF

Transforming lives through psychedelic therapy

The results indicated that CBD can alleviate primary symptoms related to drug use

Alagoan celebrates favorable decision and is optimistic about the benefits provided by the plant for better quality of life and professional performance.

“We will bring great news in our second participation in the event,” says Guilherme Santos, CEO of the company with Uruguayan roots

The main scientific and professional fair of medical cannabis takes place alongside the Brazilian Congress on Medical Cannabis

Free webinar will clarify Medicinal Cannabis Regulation in Brazil

The athlete from Espírito Santo explains how medicinal cannabis is an important ally in the intense routine of training and competitions

Unveiling the symptoms, consequences, and benefits of cannabis in treating the disease

CBCM 2024 promises new perspectives on treatments and research

Gravital Club facilitates access to cannabis-based medical treatments, as well as prescribed products

Fake dosage labels on 96% of tested CBD products

Porto Alegre's Health Secretary holds a meeting with representatives of the agenda and defines next steps to distribute medications through the Unified Health System (SUS), Legislative Assembly awaits a report from a deputy to advance discussions on cannabis

Research reveals that patients living with the disorder are more prone to using derivatives of the plant

Reports on the internet claim that both cannabis and hops are from the same plant family, and therefore, the compound present in beer produces cannabidiol. But is this claim true?

An exclusive interview with José Real, marketing manager of Cannprisma Pharma

Discovering the hidden virtues of a distinct cannabinoid